{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:25:28Z","timestamp":1788315928839,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.jpsychires.2006.01.011","type":"journal-article","created":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T07:10:13Z","timestamp":1143529813000},"page":"372-386","source":"Crossref","is-referenced-by-count":124,"title":["Long-term antipsychotic treatments and crossover studies in rats: Differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain"],"prefix":"10.1016","volume":"41","author":[{"given":"Anilkumar","family":"Pillai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Alvin V.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahebarao P.","family":"Mahadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2006.01.011_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0893-133X(02)00287-7","article-title":"Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs","volume":"27","author":"Andersson","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1461145700001759","article-title":"Chronic antipsychotics treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyltransferase in rat brain regions","volume":"3","author":"Angelucci","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0197-0186(00)00108-X","article-title":"Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics","volume":"38","author":"Balijepalli","year":"2001","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/bjp.174.1.23","article-title":"Randomized double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol","volume":"174","author":"Beasley","year":"1999","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.jcp.0000095348.32154.ec","article-title":"A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse","volume":"23","author":"Beasley","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0074-7742(04)59011-6","article-title":"Mitochondria, synaptic plasticity, and schizophrenia","volume":"59","author":"Ben-Shachar","year":"2004","journal-title":"International Review on Neurobiology"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1385\/JMN:24:2:315","article-title":"Mitochondrial enzymes in schizophrenia","volume":"24","author":"Bubber","year":"2004","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02245608","article-title":"Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, \u03b11-adrenergic and muscarinic receptors in vivo in rats","volume":"124","author":"Bymaster","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.1989.tb14918.x","article-title":"Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E","volume":"570","author":"Cadet","year":"1989","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4088\/JCP.v64n0807","article-title":"An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine","volume":"64","author":"Carlson","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib11","first-page":"36","article-title":"Mechanism of molecular action of neuroleptics","volume":"14","author":"de Erausquin","year":"2003","journal-title":"Vertex"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(95)00242-D","article-title":"Effects of antipsychotics on cognitive behavior in rats using the delayed non-match to position paradigm","volume":"28","author":"Didriksen","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2003.08.010","article-title":"Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment","volume":"69","author":"Evans","year":"2003","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00380943","article-title":"Cell loss in the hippocampus of schizophrenics","volume":"236","author":"Falkai","year":"1986","journal-title":"European Archives of Psychiatry and Neurological Sciences"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-1110(96)90004-4","article-title":"Review of the genotoxic properties of chlorpromazine and related phenothiazines","volume":"366","author":"Gocke","year":"1996","journal-title":"Mutation Research"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib16","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1176\/ajp.152.12.1730","article-title":"Tardive dyskinesia and substrates of energy metabolism in CSF","volume":"152","author":"Goff","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib17","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system","volume":"59","author":"Halliwell","year":"1992","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.ajp.158.2.176","article-title":"Studies of cognitive change in patients with schizophrenia following treatment with second-generation antipsychotics","volume":"158","author":"Harvey","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.60.6.585","article-title":"Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia","volume":"60","author":"Ho","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archpsyc.1989.01810110061009","article-title":"Hippocampal pathologic findings in schizophrenia. A morphometric study","volume":"46","author":"Jeste","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib21","first-page":"263","article-title":"Nitric oxide donors antagonize N-nitro-l-arginine and haloperidol catalepsy: potential implication for the treatment of Parkinsonism?","volume":"49","author":"Krzascik","year":"1997","journal-title":"Polish Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-3223(01)01067-8","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"Lieberman","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/schbul\/14.2.291","article-title":"Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms","volume":"14","author":"Lohr","year":"1988","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0006-3223(90)90490-S","article-title":"Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia","volume":"28","author":"Lohr","year":"1990","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.abb.2004.07.012","article-title":"Brain mitochondrial nitric oxide synthase: in vitro and in vivo inhibition by chlorpromazine","volume":"430","author":"Lores-Arnaiz","year":"2004","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3956(96)00025-8","article-title":"Cultured skin fibroblasts as a cell model for investigating schizophrenia","volume":"30","author":"Mahadik","year":"1996","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(95)00049-6","article-title":"Free radical pathology and antioxidant defense in schizophrenia: a review","volume":"19","author":"Mahadik","year":"1996","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-3223(88)90275-2","article-title":"Haloperidol alters rat cholinergic system: enzymatic and morphological analysis","volume":"24","author":"Mahadik","year":"1988","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0006-3223(97)00282-5","article-title":"Elevated plasma lipid peroxides at the onset of non-affective psychosis","volume":"43","author":"Mahadik","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib31","series-title":"Phospholipid Spectrum Disorders in Psychiatry","first-page":"99","article-title":"Membrane peroxidation and the neuropathology of Schizophrenia","author":"Mahadik","year":"1999"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0278-5846(00)00181-0","article-title":"Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia","volume":"25","author":"Mahadik","year":"2001","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib33","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/BF02980205","article-title":"Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro","volume":"26","author":"Modica-Napolitano","year":"2003","journal-title":"Archives in Pharmaceutical Research"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0920-9964(95)00048-8","article-title":"Impaired antioxidant defense at the onset of psychosis","volume":"19","author":"Mukherjee","year":"1996","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1432-1033.1978.tb12051.x","article-title":"Do mitochondria produce oxygen radicals in vivo?","volume":"82","author":"Nohl","year":"1978","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Parikh","year":"2003","journal-title":"Journal of Psychiatry Research"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2003.10.079","article-title":"Olanzapine counteracts reduction of BDNF and TrkB receptors in rat hippocampus produced by haloperidol","volume":"356","author":"Parikh","year":"2004","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpsychires.2004.03.008","article-title":"Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats","volume":"38","author":"Parikh","year":"2004","journal-title":"Journal of Psychiatry Research"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004850-199300830-00003","article-title":"Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment","volume":"8","author":"Peet","year":"1993","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/abbi.1996.0146","article-title":"Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and sub-mitochondrial particles","volume":"328","author":"Poderoso","year":"1996","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/1028415021000033767","article-title":"Role of oxidative stress and antioxidants in neurodegenerative diseases","volume":"5","author":"Rao","year":"2002","journal-title":"Nutritional Neuroscience"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0952-3278(96)90143-X","article-title":"Free radical pathology in schizophrenia: a review","volume":"55","author":"Reddy","year":"1996","journal-title":"Prostaglandins Leukotrienes and Essential Fatty Acids"},{"issue":"Suppl 11","key":"10.1016\/j.jpsychires.2006.01.011_bib43","first-page":"4","article-title":"Preclinical pharmacology of neuroleptics: focus on new generation compounds","volume":"57","author":"Richelson","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1146\/annurev.pa.36.040196.000503","article-title":"Oxidative stress in neurodegenerative diseases","volume":"36","author":"Simonian","year":"1996","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02245612","article-title":"Differential effect of antipsychotics on place navigation of rats in Morris water maze. A comparative study between novel and reference antipsychotics","volume":"124","author":"Skarsfeldt","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0006-291X(90)91936-M","article-title":"Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats","volume":"166","author":"Subramanyam","year":"1990","journal-title":"Biochemical Biophysical Research Communications"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1192\/bjp.172.6.499","article-title":"Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses","volume":"172","author":"Tran","year":"1998","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-199710000-00010","article-title":"Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders","volume":"17","author":"Tran","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib50","first-page":"169","article-title":"Oxidative stress and mitochondrial dysfunction in neurodegeneration","volume":"34","author":"Tritschler","year":"1994","journal-title":"Biochemistry and Molecular Biology International"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00212-2","article-title":"Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials","volume":"56","author":"Tuunainen","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib52","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/00001756-200312190-00028","article-title":"Effects of haloperidol and clozapine on Fos expression in the primate striatum","volume":"14","author":"Wirtshafter","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.mp.4000375","article-title":"Superoxide, neuroleptics and the ubiquinones and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients","volume":"3","author":"Whatley","year":"1998","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2006.01.011_bib54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00023210-200115040-00004","article-title":"Oxidative damage and Schizophrenia: an overview of its evidence and therapeutic implications","volume":"15","author":"Yao","year":"2001","journal-title":"CNS Drugs"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395606000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395606000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T08:25:28Z","timestamp":1547713528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395606000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0022395606000240"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2006.01.011","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}